CNBC   |  July 18, 2014

Tax implications of AbbVie-Shire

CNBC's David Faber discusses the merger between drug maker AbbVie and Shire PLC. Faber digs into the tax implications of the deal.

Share This:

Sorry, we do not have a transcript available for this video at this time.